Compounded formulation • Prescribed by licensed medical provider
Click thumbnails above to switch between medication view, clinical highlights, and care standards.
PT-141 (Bremelanotide)
Melanocortin pathway support for sexual wellness
PT-141 (Bremelanotide) is a peptide that acts through melanocortin pathways in the central nervous system rather than functioning like traditional PDE5 erectile-dysfunction medications. Use in men is off-label, and compounded PT-141 is not FDA-approved for male sexual dysfunction. Available as a provider-guided option with 4-week and 12-week supply options.
Available Supply Options
Prices shown are total supply-period prices. Dose and supply are determined by your provider based on clinical eligibility.
4-Week Supply
ONE-TIME12-Week Supply
SUBSCRIPTIONWhat is PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH) that acts on melanocortin receptors in the central nervous system.
Unlike traditional PDE5 inhibitor erectile-dysfunction medications (such as sildenafil or tadalafil) that act peripherally on vascular blood flow, PT-141 works through the central nervous system via melanocortin pathways involved in sexual desire and arousal.
Compounded PT-141 is available through Reform MD Rx as a medication prepared by a licensed compounding pharmacy pursuant to an individualized prescription issued by a licensed provider.
Why Patients Explore PT-141 (Bremelanotide)
Individuals interested in supporting sexual desire and sexual wellness through a central nervous system pathway may explore PT-141 as a provider-guided option.
Some patients explore PT-141 because it works through a different mechanism than traditional PDE5 medications.
Patients who have discussed their sexual wellness goals with a licensed provider and have been evaluated as clinically appropriate candidates may consider this option.
How Treatment Works
PT-141 acts as an agonist at melanocortin receptors (MC3R and MC4R) in the central nervous system, pathways involved in sexual desire and arousal.
This mechanism is distinct from PDE5 inhibitors, which act peripherally on vascular blood flow.
Treatment and dosing are determined by the prescribing provider based on clinical eligibility.
What to Expect
You begin by completing a secure, confidential medical evaluation covering your health history, medications, and wellness goals.
A licensed provider reviews your evaluation to determine whether a PT-141 protocol is clinically appropriate for you.
If a prescription is issued, your medication is compounded by a licensed pharmacy and shipped discreetly in temperature-controlled packaging.
Follow-up check-ins allow your provider to monitor your response and adjust your plan as clinically indicated.
Key Program Features
Discreet & Temperature-Controlled Delivery
After provider approval and pharmacy processing, delivery typically takes 3 to 5 days. All shipments arrive in temperature-monitored, discreet packaging to maintain stability.
PT-141 (Bremelanotide) FAQ
Explore complementary support for your treatment plan
Explore optional supportive treatments. Each prescription option requires a separate clinical assessment and is available only when prescribed. Additional costs apply.
More provider-guided options
Explore PT-141 (Bremelanotide) with a Licensed Provider
Add PT-141 (Bremelanotide) to your cart, accept the Terms & Conditions, complete the required medical intake form, and pay at checkout. A licensed provider then reviews your intake to determine eligibility.
Payment is collected at checkout before the provider evaluation. Prescriptions are not guaranteed. If a provider does not approve treatment, the medication is refunded; the consultation/evaluation fee is retained.